These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 32266255)

  • 41. Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling.
    Tang Y; Chen M; Zhou L; Ma J; Li Y; Zhang H; Shi Z; Xu Q; Zhang X; Gao Z; Zhao Y; Cheng Y; Jiao S; Zhou Z
    Cell Discov; 2019; 5():3. PubMed ID: 30622739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tales of RAM and MOR: NDR kinase signaling in fungal morphogenesis.
    Maerz S; Seiler S
    Curr Opin Microbiol; 2010 Dec; 13(6):663-71. PubMed ID: 20869909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation.
    Hergovich A; Bichsel SJ; Hemmings BA
    Mol Cell Biol; 2005 Sep; 25(18):8259-72. PubMed ID: 16135814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STRIPAK Dependent and Independent Phosphorylation of the SIN Kinase DBF2 Controls Fruiting Body Development and Cytokinesis during Septation and Ascospore Formation in
    Shariatnasery M; Stein V; Teichert I; Kück U
    J Fungi (Basel); 2024 Feb; 10(3):. PubMed ID: 38535186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Hippo Pathway-Related GCK Controls Both Sexual and Vegetative Developmental Processes in the Fungus
    Radchenko D; Teichert I; Pöggeler S; Kück U
    Genetics; 2018 Sep; 210(1):137-153. PubMed ID: 30012560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.
    Couzens AL; Knight JD; Kean MJ; Teo G; Weiss A; Dunham WH; Lin ZY; Bagshaw RD; Sicheri F; Pawson T; Wrana JL; Choi H; Gingras AC
    Sci Signal; 2013 Nov; 6(302):rs15. PubMed ID: 24255178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STRIPAK integrates upstream signals to initiate the Hippo kinase cascade.
    Chen R; Xie R; Meng Z; Ma S; Guan KL
    Nat Cell Biol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31792377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
    Ni L; Luo X
    Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
    Furth N; Aylon Y
    Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
    Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HAM-2 and HAM-3 are central for the assembly of the Neurospora STRIPAK complex at the nuclear envelope and regulate nuclear accumulation of the MAP kinase MAK-1 in a MAK-2-dependent manner.
    Dettmann A; Heilig Y; Ludwig S; Schmitt K; Illgen J; Fleißner A; Valerius O; Seiler S
    Mol Microbiol; 2013 Nov; 90(4):796-812. PubMed ID: 24028079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
    Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
    Elife; 2017 Oct; 6():. PubMed ID: 29063833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
    Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
    Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation mechanisms of the Hippo kinase signaling cascade.
    Bae SJ; Luo X
    Biosci Rep; 2018 Sep; 38(4):. PubMed ID: 30038061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
    Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
    Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.